Quercetin and trichostatin A cooperatively kill human leukemia cells

Pharmazie

Volumn 60, Issue 11, 2005, Pages 856-860

  Chen, Jie ^b   Kang, Jiu Hong ^a  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; MALONALDEHYDE; QUERCETIN; REACTIVE OXYGEN METABOLITE; TRICHOSTATIN A;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL;

ACETYLATION; ACYLATION; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; HISTONES; HL-60 CELLS; HUMANS; HYDROXAMIC ACIDS; LEUKEMIA; MALONDIALDEHYDE; QUERCETIN; REACTIVE OXYGEN SPECIES;

EID: 28244487768     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Archer SY, Hodin RA (1999) Histones acetylation and cancer. Curr Opin Gene Devel 9: 171-174.
2. Chan MM, Fong D, Soprano KJ, Holmes WF, Heverling H (2003) Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol 194: 63-70.
3. Chen J, Ou YX, Da WM, Kang JH (2004a) Coadjustment of quercetin and hydrogen peroxide: the role of ROS in the cytotoxicity of quercetin. Pharmazie 59: 155-158.
4. Chen J, Kang JH, Da WM, Ou YX (2004b) Combination with water-soluble antioxidants increases the anticancer activity of quercetin in human leukemia cells. Pharmazie 59: 859-863.
5. Cipak L, Rauko P, Miadokova E, Cipakova I, Novotny L (2003) Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells. Leuk Res 27: 65-72.
6. Conklin KA (2000) Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37: 1-18.
7. Cousens LS, Gallwitz D, Alberts BM (1979) Different accessibilities in chromatin to histone acetylase. J Biol Chem 254: 1716-1723.
8. Deshpande SS, Irani K (2002) Oxidant signalling in carcinogenesis: a commentary. Hum Exp Toxicol 21: 63-64.
9. Donadelli M, Costanzo C, Faggioli L, Scupoli MT, Moore PS, Bassi C, Scarpa A, Palmieri M (2003) Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinogen 38: 59-69.
10. Drisko JA, Chapman J, Hunter VJ (2003) The use of antioxidant therapies during chemotherapy. Gynecol Oncol 88: 434-439.
11. Duthie GG, Duthie SJ, Kyle JAM (2000) Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants. Nutr Res Rev 13: 79-106.
12. Feng Q, Kumagai T, Torii Y, Nakamura Y, Osawa T, Uchida K (2001) Anticarcinogenic antioxidants as inhibitors against intracellular oxidative stress. Free Radic Res 35: 779-788.
13. Fry CJ, Peterson CL, (2002) Unlocking the gates to gene expression. Science 295: 1847-1848.
14. Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389: 349-352.
15. Gutteridge JMC, Halliwell B (1990) The mesurement and mechanism of lipid peroxidation in biological system. Trends Biochem Sci 15: 129-135.
16. Hendersona C, Brancolini C (2003) Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotype. Drag Resist Updates 6: 247-256
17. Hollman PC, Van Trijp JM, Mengelers MJ, de Vries JH, Katan MB (1997) Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett 114: 139-140.
18. Kaneuchi M, Sasaki M, Tanaka Y, Sakuragi N, Fujimoto S, Dahiya R (2003) Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. Int J Oncol 22: 159-164.
19. Kang J, Chen J, Zhang D, Da W, Ou Y (2004) Synergistic killing of human leukemia cells by antioxidants and trichostatin A. Cancer Chemother Pharmacol 54: 537-545.
20. Kang J, Shi Y, Zheng R (1999) Effects of ascorbic acid on human hepatoma cell proliferation and redifferentiation. Acta Pharmacol Sin 20: 1019-1024.
21. Kang JH, Shi YM, Zheng RL (2000) Effects of ascorbic acid and DL-alpha-tocopherol on human hepatoma cell proliferation and redifferentiation. Acta Pharmacol Sin 21: 348-352.
22. Kang J, Zhang Y, Chen J, Chen H, Lin C, Wang Q, Ou Y (2003) Nickel-induced histone hypoacetylation: the role of reactive oxygen species. Toxicol Sci 74: 279-286.
23. Kang TB, Liang NC (1997) Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54: 1013-1018.
24. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M (1999) Effect of citrus flavonoids on HL-60 cell differentiation. Anticancer Res 19(2A): 1261-1269.
25. Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F (2003) Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 63: 7291-7300.
26. Kim SY, Gao JJ, Kang HK (2000) Two flavonoids from the leaves of Morus alba induce differentiation of the human promyelocytic leukemia (HL-60) cell line. Biol Pharm Bull. 23: 451-455.
27. Klochendler-Yeivin A, Yaniv M, (2001) Chromatin modifiers and tumor suppression. Biochim Biophys Acta 1551: M1-M10.
28. Kuo HM, Ho HJ, Chao PD, Chung JG (2002) Quercetin glucuronides inhibited 2-aminofluorene acetylation in human acute myeloid HL-60 leukemia cells. Phytomedicine 9: 625-631.
29. Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT (2002). Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res 22: 1615-1627.
30. Lehrmann H Pritchard LL Harel-Bellan A (2002) Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation. Adv Cancer Res 86: 41-65.
31. Liesveld JL, Abboud CN, Lu C, McNair C, Menon A, Smith A, Rosell K, Rapoport AP (2003) Flavonoid effects on normal and leukemic cells. Leuk Res 27: 517-527.
32. Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Nat Cancer Inst 92: 1210-1216.
33. Marks PA, Richon VM, Breslow R, Rifkind RA (2001) Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 13: 477-483
34. Morand C, Crespy V, Manach C, Besson C, Demigné C, Rémésy C (1998) Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 275: R212-219.
35. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
36. Prasad KN, Kumar A, Kochupillai V, Cole WC (1999) High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 18: 13-25.
37. Rosato RR, Grant S (2003) Histone deacetylase inhibitors in cancer therapy. Cancer Biol Ther 2: 30-37.
38. Uddin S, Choudhry MA (1995) Quercetin, a bioflavonoid, inhibits the DNA synthesis of human leukemia cells. Biochem Mol Biol Int 36: 545-550.
39. Wang PF, Kang JH, Zheng RL, Lu JF, Yang ZF, Jia ZJ, Gao JJ (1996) Scavenging effects of phenylpropanoid glycosides from Pedicularis on Superoxide anion and hydroxyl radical by the spin trapping method. Biochem Pharmacol 51: 687-691.
40. Yamashita Y, Shimada M, Harimoto N, Rikimani T, Shirabe K, Tanaka S, Sugimachi K (2003) Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer 103: 572-576.